FDA Inspection 1209948 — University Of Iowa Pharmaceuticals

University Of Iowa Pharmaceuticals — FEI 1918751

The FDA completed an inspection of University Of Iowa Pharmaceuticals on Jun 22, 2023 in Iowa City, IA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 22, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Iowa City, IA (United States)